ABBOTT LABORATORIES (ABT) Form 8-K — Jul 16, 2026
Abbott reported second-quarter sales of $12.59 billion, a 13.0% increase on a reported basis and 4.8% on a comparable basis, driven primarily by the recent acquisition of Exact Sciences and growth in the Medical Devices segment. The company declared a quarterly dividend of $0.63 per share, marking its 410th consecutive quarterly dividend. Despite the revenue growth, GAAP diluted earnings per share fell to $0.53 from $1.01 in the prior year, largely due to significant one-time charges including $385 million for legal reserves and acquisition-related amortization. Adjusted diluted EPS, which excludes these items, rose to $1.31.
Key figures
- Eps
- 0.53
- Revenue
- 12593
- Guidance
- Full-year 2026 comparable sales growth of 6.5% to 7.5%; Adjusted diluted EPS $5.45 to $5.60
- Net Income
- 928
- Adjusted EPS
- 1.31
- Dividend Per Share
- 0.63
- Reported Sales Growth
- 13.0%
- Comparable Sales Growth
- 4.8%
Price after filing
Close on the filing date to close N calendar days later (from $92.11). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.